Supplemental material
Expert Review of Vaccines
Volume 16, 2017 - Issue 8
Related Research Data
The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy.
Source:
Springer Science and Business Media LLC
Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens.
Source:
Ovid Technologies (Wolters Kluwer Health)
Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study.
Source:
Briefland
Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years.
Source:
Elsevier BV
Immunological cure of HBV infection
Source:
Springer Science and Business Media LLC
Protective Efficacy of a Recombinant DNA Hepatitis B Vaccine in Neonates of HBe Antigen—Positive Mothers
Source:
American Medical Association (AMA)
Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients
Source:
Elsevier BV
Are booster immunisations needed for lifelong hepatitis B immunity?
Source:
Elsevier BV
Hepatitis B vaccination in mentally retarded: Effectiveness after 11 years
Source:
Elsevier BV
Long-Term Humoral and Cellular Immune Response to Hepatitis B Vaccine in High-Risk Children 18–20 Years After Neonatal Immunization
Source:
Mary Ann Liebert Inc
Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen
Source:
Elsevier BV
Comparative Study of the Immunogenicity And Safety of Two Doses of Recombinant Hepatitis B Vaccine in Healthy Adolescents
Source:
Elsevier BV
Hepatitis B vaccination during pregnancy
Source:
Wiley
Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B® hepatitis B vaccine in neonates
Source:
Ovid Technologies (Wolters Kluwer Health)
Assessment of long-term efficacy of hepatitis B vaccine.
Source:
Springer Science and Business Media LLC
Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was Launched
Source:
Oxford University Press (OUP)
Maternal antibodies provide partial protection from postnatal Zika viremia in nonhuman primates
Source:
bioRxiv
Antibody levels in children after 10 years of vaccination against hepatitis B: a brazilian community-based study
Source:
Sociedade Brasileira de Medicina Tropical - SBMT
Acute Hepatitis B After the Implementation of Universal Vaccination in Italy: Results From 22 Years of Surveillance (1993–2014)
Source:
Oxford University Press (OUP)
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.
Source:
Ovid Technologies (Wolters Kluwer Health)
Response of preterm infants to hepatitis B vaccine.
Source:
Elsevier BV
Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand.
Source:
Elsevier BV
HSU ET AL.
Source:
Wiley
Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Source:
Elsevier BV
Correlates of Protection Induced by Vaccination
Source:
American Society for Microbiology
Association of Infectious Mononucleosis with Multiple Sclerosis
Source:
S. Karger AG
Female Children Respond to Recombinant Hepatitis B Vaccine with a Higher Titre than Male
Source:
Oxford University Press (OUP)
Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
Source:
Elsevier BV
Eficácia e segurança da vacina brasileira contra hepatite B em recém-nascidos
Source:
Faculdade de Saúde Pública da Universidade de São Paulo
Assessment of a universal, school-based hepatitis B vaccination program.
Source:
American Medical Association (AMA)
A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart.
Source:
Elsevier BV
Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age
Source:
Elsevier BV
Antibody levels in Ethiopian children five years after vaccination with two different doses of hepatitis B vaccine: is there a need for booster vaccine?
Source:
Hindawi Limited
Hepatitis B vaccination in acute lymphoblastic leukemia
Source:
Elsevier BV
Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination.
Source:
Informa UK Limited
Hepatitis B vaccination of adolescents: significance of non-protective antibodies.
Source:
Elsevier BV
Two booster dose hepatitis B virus vaccination in patients with leukemia.
Source:
Elsevier BV
Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia
Source:
Springer Science and Business Media LLC
Protection against hepatitis B after 20 years
Source:
Wiley
Hepatitis B response of premature infants after primary and booster immunisation with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus/haemophilus influenzae type B vaccine.
Source:
Hindawi Limited
Importance of attributable risk in monitoring adverse events after immunization: hepatitis B vaccination in children.
Source:
American Public Health Association
Imunização contra Hepatite B em crianças de zona endêmica: avaliação da resposta de anticorpo à vacina HB recombinante (Engerix B-20mcg)
Source:
Instituto de Medicina Tropical
Efficacy With Hepatitis B Immune Globulin in Prevention of Perinatal Hepatitis B Virus Transmission
Source:
American Medical Association (AMA)
Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy.
Source:
Elsevier BV
Linking provided by
